Finance

Lists
HBMN:SWX
HBM Healthcare Investments AG
CHF 254.50
+1.80%
(+4.50) 1D
Jul 27, 1:23:09 PM GMT+2  ·   CHF
All symbols
SymbolPriceChange% Change
Generating top insights for HBMN...
Open
CHF 250.00
High
CHF 255.00
Low
CHF 250.00
Mkt. cap
1.68B
Avg. vol.
4.79K
Volume
1.23K
Dividend
3.54%
Quarterly dividend
CHF 2.25
Ex-dividend date
Jun 17, 2026
P/E ratio
2.60
52-wk high
CHF 258.00
52-wk low
CHF 160.80
EPS
CHF 97.76
Shares outstanding
6.62M
Open
CHF 250.00
High
CHF 255.00
Low
CHF 250.00
Mkt. cap
1.68B
Avg. vol.
4.79K
Volume
1.23K
Dividend
3.54%
Quarterly dividend
CHF 2.25
Ex-dividend date
Jun 17, 2026
P/E ratio
2.60
52-wk high
CHF 258.00
52-wk low
CHF 160.80
EPS
CHF 97.76
Shares outstanding
6.62M
News stories
From sources across the web
Profile
HBM Healthcare Investments is a publicly traded Swiss investment and venture capital firm focusing on emerging technologies in the global healthcare sector. Within healthcare their focus is predominantly in biotechnology, medical technology, diagnostics, therapeutics and digital health. A 2022 article in Swiss daily Luzerner Zeitung profiled HBM and interviewed its CEO, and described the company’s investment strategy as focused on early-stage but post-seed round opportunities. Founded in July 2001 as HBM Bioventures AG by former Roche Chief Financial Officer Henri B. Meier who was its first Chairperson of the Board. A Handelszeitung article from 2020 described Meier's goal when founding the company as to profit from the "thesis" that from the 2000s onwards "Big Pharma is doing less and less research and development itself and is instead acquiring promising biotech companies" In an analysis of how HBM was put together, Swiss magazine Finanz und Wirtschaft described how he was able to raise almost 500 million Swiss Francs for the company launch. HBM is based in Zug and managed by HBM Partners. HBM acquired rival Swiss VC International BM Biomedicine in 2005. Wikipedia
About HBM Healthcare Investments AG
CEO-
Employees-
FoundedJul 12, 2001
HeadquartersZug, Zug, Switzerland
SectorCapital market
Websitehbmhealthcare.com
Last report
Oct 23, 2026
Fiscal period
Q1 2027
EPS / Est. (CHF)
- / -
Revenue / Est. (CHF)
239.30M / -
Fiscal Q1 2027 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in CHF
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in CHF
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
236.69M
191.76M
-13.57M
239.30M
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
394.00K
395.00K
397.00K
395.00K
Operating expense
726.00K
575.00K
671.00K
653.00K
Total operating expenses
726.00K
575.00K
671.00K
653.00K
Operating income
235.96M
191.18M
-14.24M
238.65M
Other non operating income
-
-
-
-
EBT including unusual items
235.62M
190.85M
-14.57M
238.32M
EBT excluding unusual items
235.62M
190.85M
-14.57M
238.32M
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
332.00K
180.00K
274.00K
258.00K
Net income
235.62M
190.85M
-14.57M
238.32M
Net profit margin
99.55%
99.53%
107.36%
99.59%
Earnings per share
-
-
-
-
Interest and investment income
-
-
-
-
Interest expense
-339.00K
-328.00K
-328.00K
-331.00K
Net interest expenses
-339.00K
-328.00K
-328.00K
-331.00K
Depreciation and amortization charges
-
-
-
-
EBITDA
-
-
-
-
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

What's on your mind?
What's going on with the markets today?
Explore what’s possible
Create a portfolio
Create a task
Deep Search
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer